Advances in research into the 85 cannabinoid compounds found in marijuana have documented many potential therapeutic applications. This panel of leading researchers and drug development company executives discuss the latest discoveries of these compounds’ interactions with the human endocannabinoid system, and the implications for new drug development.
Seth Yakatan, Kalytera Therapeutics; Dr. Mowgli Holmes, Phylos Bioscience; Dr. Mark Rosenfeld, ISA Scientific; Dr. Lui Franciosi, Veritas Pharma